Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 1,093 | 1,687 | 1,872 | 2,079 | 934 |
| Gross Profit | 1,093 | 1,687 | 1,872 | 2,079 | 934 |
| Operating Expenses | 32,234 | 24,946 | 19,934 | 18,740 | 11,283 |
| Operating Income | -31,141 | -23,259 | -18,062 | -16,661 | -10,349 |
| Interest Expense | 33 | 38 | 42 | 47 | 9 |
| Other Income | 124 | -24 | 16 | 146 | 151 |
| Pre-tax Income | -31,050 | -23,321 | -18,088 | -16,562 | -10,207 |
| Income Tax | 130 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -31,180 | -23,321 | -18,088 | -16,562 | -10,207 |
| Minority Interests | N/A | N/A | 1 | -349 | -233 |
| Net Income | $-31,180 | $-23,321 | $-18,089 | $-16,213 | $-9,974 |
| EPS Basic Total Ops | -11.07 | -10.08 | -26.82 | -43.56 | -28.44 |
| EPS Basic Continuous Ops | -11.10 | -10.10 | -26.84 | -44.47 | -29.07 |
| EPS Diluted Total Ops | -11.07 | -10.08 | -26.82 | -43.56 | -28.44 |
| EPS Diluted Continuous Ops | -11.10 | -10.10 | -26.84 | -44.47 | -29.07 |
| EBITDA(a) | $-30,250 | $-22,471 | $-17,375 | $-16,006 | $-10,046 |